1. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. (16th December 2014) Authors: Nemes, Elisa; Kagina, Benjamin M. N.; Smit, Erica; Africa, Hadn; Steyn, Marcia; Hanekom, Willem A.; Scriba, Thomas J. Journal: Cytometry Issue: Volume 87:Number 2(2015) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Issue 33 (7th August 2015) Authors: Luabeya, Angelique Kany Kany; Kagina, Benjamin M.N.; Tameris, Michele D.; Geldenhuys, Hennie; Hoff, Soren T.; Shi, Zhongkai; Kromann, Ingrid; Hatherill, Mark; Mahomed, Hassan; Hanekom, Willem A.; Andersen, Peter; Scriba, Thomas J.; H56-032 Trial Study Group, 1; Schoeman, Elisma; Krohn, Colleen; D... Journal: Vaccine Issue: Volume 33:Issue 33(2015) Page Start: 4130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Issue 33 (7th August 2015) Authors: Luabeya, Angelique Kany Kany; Kagina, Benjamin M.N.; Tameris, Michele D.; Geldenhuys, Hennie; Hoff, Soren T.; Shi, Zhongkai; Kromann, Ingrid; Hatherill, Mark; Mahomed, Hassan; Hanekom, Willem A.; Andersen, Peter; Scriba, Thomas J.; Schoeman, Elisma; Krohn, Colleen; Day, Cheryl L.; Africa, Hadn; M... Journal: Vaccine Issue: Volume 33:Issue 33(2015) Page Start: 4130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial. Issue 1 (3rd January 2017) Authors: Rozot, Virginie; Abrahams, Deborah A.; Mauff, Katya; Smit, Erica; Brown, Yolande; Hughes, E. Jane; Makgotlho, Edward; Keyser, Alana; Erasmus, Mzwandile; Makhethe, Lebohang; Africa, Hadn; Hopley, Charles; Steyn, Marcia; Mearns, Helen; Geldenhuys, Hennie D.; Kagina, Benjamin M.; Musvosvi, Munyaradz... Journal: Vaccine Issue: Volume 35:Issue 1(2017) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Heterologous vaccination against human tuberculosis modulates antigen‐specific CD4+ T‐cell function. Issue 9 (8th July 2013) Authors: Dintwe, One B.; Day, Cheryl L.; Smit, Erica; Nemes, Elisa; Gray, Clive; Tameris, Michele; McShane, Helen; Mahomed, Hassan; Hanekom, Willem A.; Scriba, Thomas J. Journal: European journal of immunology Issue: Volume 43:Issue 9(2013:Sep.) Page Start: 2409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial. Issue 9 (September 2019) Authors: Tameris, Michele; Mearns, Helen; Penn-Nicholson, Adam; Gregg, Yolande; Bilek, Nicole; Mabwe, Simbarashe; Geldenhuys, Hennie; Shenje, Justin; Luabeya, Angelique Kany Kany; Murillo, Ingrid; Doce, Juana; Aguilo, Nacho; Marinova, Dessislava; Puentes, Eugenia; Rodríguez, Esteban; Gonzalo-Asensio, Jesú... Journal: Lancet Issue: Volume 7:Issue 9(2019) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial. Issue 4 (April 2021) Authors: Day, Tracey A; Penn-Nicholson, Adam; Luabeya, Angelique Kany Kany; Fiore-Gartland, Andrew; Du Plessis, Nelita; Loxton, Andre G; Vergara, Julie; Rolf, Tom A; Reid, Tim D; Toefy, Asma; Shenje, Justin; Geldenhuys, Hendrik; Tameris, Michele; Mabwe, Simbarashe; Bilek, Nicole; Bekker, Linda-Gail; Diaco... Journal: Lancet Issue: Volume 9:Issue 4(2021) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial. Issue 4 (April 2021) Authors: Day, Tracey A; Penn-Nicholson, Adam; Luabeya, Angelique Kany Kany; Fiore-Gartland, Andrew; Du Plessis, Nelita; Loxton, Andre G; Vergara, Julie; Rolf, Tom A; Reid, Tim D; Toefy, Asma; Shenje, Justin; Geldenhuys, Hendrik; Tameris, Michele; Mabwe, Simbarashe; Bilek, Nicole; Bekker, Linda-Gail; Diaco... Journal: Lancet Issue: Volume 9:Issue 4(2021) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial. Issue 4 (April 2018) Authors: Penn-Nicholson, Adam; Tameris, Michele; Smit, Erica; Day, Tracey A; Musvosvi, Munyaradzi; Jayashankar, Lakshmi; Vergara, Julie; Mabwe, Simbarashe; Bilek, Nicole; Geldenhuys, Hendrik; Luabeya, Angelique Kany-Kany; Ellis, Ruth; Ginsberg, Ann M; Hanekom, Willem A; Reed, Steven G; Coler, Rhea N; Scri... Journal: Lancet Issue: Volume 6:Issue 4(2018) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗